ERIKA SELA INNOVATEC (SPAIN)

SRTD II and EU-Jordan Net II Workshop, Amman (Jordan), 23-24 March 2015

• A short introduction of myself and my work in the Spanish company INNOVATEC

• My experience in participating in framework programmes (FP7 & H2020), and some ideas on international cooperation activities.

• Advises and ideas to help Jordanian researchers to enhance and strengthen their cooperation with European counterparts, based on my experience and know-how of European programmes and international R&D collaboration.

INNOVATEC is an independent Spanish firm, established in 1999, specialized in science, technology and innovation. We provide qualified and tailor-made consultancy services in the field of Research, Development & Innovation to public authorities, companies and research organizations. Our main areas of work are:

Coordination and partnering in EU funded projects (Public health research, R&D policy, RRI, Research impact,..).

Developing and implementing Monitoring and Evaluation (M&E) methodologies and tools for R&D and innovation (policies, programmes and projects).

Support Regional Innovation Strategies (RIS3) plans.

Promoting Responsible Research and Innovation (RRI) in research institutions.

Dissemination plans and stakeholder analysis for research actions.

EXPERIENCE IN EUROPEAN PROJECTS AS COORDINATORS

H2020: RegHealth-RI: The European Regions Network for Health Research & Innovation. (Nov 2014-Oct 2017). http://www.rhing-net.eu/reghealth-ri/

FP7: EVAL-HEALTH: Developing and Testing of New Methodologies to Monitor and Evaluate Health Related EU-Funded Interventions in Cooperation Partner Countries. Jan 2013 - Oct 2014. www.eval-health.eu

FP7. EUROECOTOX: European Network for Alternative Testing Strategies in Ecotoxicology. Dec 2010 -Nov 2012 ZF Biolabs. https://sites.google.com/a/euroecotox.eu/networkeuroecotox/HOME

AS PARTNERS H2020: COLUMBUS: Monitoring, Managing and Transferring Marine and Maritime

Knowledge for Sustainable Blue Growth. Mar 2015-Feb 2018.

H2020: HEIRRI: Higher education institutions and responsible research and Innovation. Under grant agreement negotiation.

FP7 EU-LAC Health: Defining a Roadmap for Cooperative Health Research between the EU and Latin America-Caribbean countries: a Policy Oriented Approach. Oct 2011-Sept 2016. www.eulachealth.eu

DEVELOPING AND TESTING OF NEW METHODOLOGIES TO MONITOR AND EVALUATE HEALTH RELATED EU-FUNDED INTERVENTIONS IN COOPERATION PARTNER COUNTRIES

COLLABORATIVE RESEARCH PROJECT. Specific International Cooperation Action funded by the 7TH FRAMEWORK PROGRAMME OF THE EUROPEAN COMMISSION. INTERNATIONAL PUBLIC HEALTH

EVAL-HEALTH PROJECT

• ANALYSIS OF THE ROLE OF EVIDENCES IN HEALTH POLICY DEVELOPMENT IN LOW AND MIDDLE-INCOME COUNTRIES: The aim of this research is to identify and analyze the role of different types of evidences in health policy in two countries (India and Nigeria), including research results.

• DEVELOPMENT AND TESTING OF A NEW METHODOLOGY TO MONITOR AND EVALUATE THE IMPACT OF RESEARCH PROJECTS: The main goal of this research is to develop and validate a new methodology to support the Directorate-General for Research and Innovation of the European Commission in their task to monitor and assess the impact of research projects that have been funded in the area of International Public Health.

EVAL-HEALTH RESEARCH COMPONENTS

EVAL-HEALTH PROJECT PARTNERS:

1.INNOVATEC (Spain) Coordinator

2.African Union New Partnership for Africa’s Development (South Africa)

3.University of Leeds (UK)

4.Royal Tropical Institute (Netherlands)

5.Institute for Health and Tropical Medicine (Portugal)

6.Mahidol University (Thailand)

7.Association for Stimulating Know-How (India)

8.University of Nigeria, Enugu Campus (Nigeria)

9.Rosario University (Colombia) www.eval-health.eu

EVAL-HEALTH IN NUMBERS

Duration: 46 months Nº of researchers: 24-30 - PM effort: 349 Nº face to face project meetings: 8Nº dissemination activities: 17Meetings with the EC: 6Peer review publications: 1 and 4-6 (under preparation)Policy Briefs: 8Periodic reports (technical and financial): 3 + final reportTotal project cost: 3,48 Mill EUR - Total EU contribution: 2,

86 Mill EUR

EU-LAC HEALTH: Defining a Roadmap for cooperative health research between the EU and Latin America-Caribbean countries: a policy-oriented approach (www.eulachealth.eu) Explore, with policy-makers and other stakeholders, how to best coordinate

health research policies and funding between EU and LAC. Establish a consensus Roadmap for cooperative health research for

collaboration between the EU and LAC regions. Promote the creation of a Coordinating Body to develop the Roadmap. Disseminate the project results to relevant stakeholders to increase and

improve EU-LAC cooperation in health research.

INTERNATIONAL COLLABORATION IN H2020

HORIZON 2020 is open to legal entities from across the world

JORDAN is one of the countries automatically eligible for funding in H2020.

In addition to this general openness of most Horizon 2020 calls to non-EU researchers, many calls particularly encourage cooperation with non-EU partners. In the H2020 Work programme 2014-2015, there are a total of 13 topics which encourage cooperation (or even include it as an eligibility criteria) with the SOUTHERN MEDITERRANEAN COUNTRIES (Algeria, Morocco, Egypt, Israel, JORDAN, Lebanon, Libya, Palestine, Tunisia and Syria). None of these topics is from the area of Health.(S. Challenge 1).

FUNDING OPTIONS FOR HEALTH RESEARCH GROUPS

BASIC RESEARCH: Career development grants in Europe European Research Council (ERC) and Marie Marie Sklodowska

Curie Action (MSCA).

BASIC AND APPLIED RESEARCH & INNOVATION : H2020 CALLS Societal Challenge 1: Health, demographic change and wellbeing Work programme 2014-2015: last calls for 2015 health close next 21 April

Work programme 2016-2017, to be adopted in the third quarter 2015.

Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE): short-term mobility (secondment = exchanges) of research and innovation staff at all career levels, including post-docs, administrative and technical staff. Deadline Date28-04-2015

http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/9079-msca-rise-2015.html

BENEFITS FROM PARTICIPATING IN EU COLLABORATIVE RESEARCH PROJECTS

SOME DATA FROM PREVIOUS FRAMEWORK PROGRAMMES – funded health projects with

Jordan partners

FP 7 (2007-2013) HEALTH PROGRAMME. AREA 3.4 International public health & health systems• RESCAP-MED - NCDs and their social determinants in Mediterranean partner countries: building sustainable research capacity for effective policy intervention. Jordan partner: JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY

FP6 (2002-2006) Support to International Cooperation (INCO) B.3 HEALTH•BEDOUIN HEALTH - Improving access to and quality of reproductive and child health care to marginal peoples:Bedouin in Jordan and Syria. Partner: Philadelphia University

•MEDGENET - Euro-Mediterranean Network for Genetic Services. Partner: National Center For Diabetes, Endocrine And Genetic Diseases

•LEISH-MED - Monitoring risk factors of spreading of leishmaniasis around the Mediterranean basin. Partner: Dept. Biological Sciences, Yarmouk University

OPTIONS FOR JORDAN HEALTH RESEARCH GROUPS TO PARTICIPATE IN H2020 CALLS -1

READ THOROUGHLY the Biannual work programme for Societal challenge 1 and look for topic(s) in which your research work and expertise fits. If topics are found:

1. Try to find someone from a EU member state who can coordinate and who will be willing to invite you to join the consortium.

2. Find a consortium already set up and see if you can join.

3. Coordinate a proposal (Only possible for very limited cases, topics specifically requesting international coordination).

OPTIONS FOR JORDAN HEALTH RESEARCH GROUPS TO PARTICIPATE IN H2020 CALLS -2

CONTACTING LOCAL NCPS THAT CAN DISSEMINATE YOUR INTEREST IN TOPICS

NETWORKING WITH EUROPEAN RESEARCH GROUPS: Jordanian researchers working in Europe (need to be identified)

Social media (LinkedIn groups H2020)

Networking, Brokerage events and Conferences organized in Europe

Jordan MSCA grantees can be a good link to EU research groups.

Participate in international programmes funded by European Countries (ie. Programme for Global Health and Vaccination Research – GLOBVAC – Norway)

Participate in multilateral health initiatives: Global Alliance for Chronic diseases, GLOBE network

OPTIONS FOR JORDAN HEALTH RESEARCH GROUPS TO PARTICIPATE IN H2020 CALLS -3

MAKE YOUR RESEARCH RESULTS VISIBLE: Open Access Journals: PLoS ONE

Open Access repositories: Research gate, Fig share,

PUBLISH PROFILES AND PROJECT INTEREST: euMatch 2.0 Partner Search and Matchmaking platform

LOOK FOR PROJECTS IN CORDIS TO FIND PARTNERS http://cordis.europa.eu/projects/home_en.html

FINAL REFLECTIONS - I International Collaborative research is growing as

results of the need to address global health challenges with large interdisciplinary, multinational projects.

H2020 is the biggest research programme funding collaborative research in health (7,5 Bill EUR)

In H2020 International partners are welcome but they need to contribute with excellent science and expertise. More difficulties for Low and Middle income countries as there are no specific programmes for international collaboration and international calls (around 20% in 1st. WP) encourage but not oblige international participation.

FINAL REFLECTIONS - II

Bilateral projects such as EU Jordanet II and SRTD-II can stimulate the policy dialogue with the EU and contribute towards an increased visibility of Jordan researchers and institutions.

Priorities for future cooperation with the EU must include the regional component. The Euro Mediterranean Group of Senior Officials in Research and Innovation (EU-MEd GSO) can play a central role in stimulating the Euro-Mediterranean cooperation in health research and Innovation. Shared health problems such as rare disease, infectious diseases and NCDs are priority areas for collaboration and effort should be placed towards promoting topics in future H2020 programmes specifically addressing research collaboration between both regions in this fields. 

SUGGESTED REFERENCES

HORIZON 2020, Health, Demographic change and wellbeing http://ec.europa.eu/programmes/horizon2020/en/h2020-section/health-demographic-change-and-wellbeing

Report from the Commission to the European parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Report on the Implementation of the strategy for international cooperation in research and innovation COM(2014) 567 final http://ec.europa.eu/research/iscp/pdf/policy/progress_report_sep-2014.pdf

Roadmap for cooperation in research and innovation between the Southern Mediterranean and the European Union http://ec.europa.eu/research/iscp/pdf/policy/annex_roadmaps_sep-2014.pdf

Global Link for Online Biomedical Expertise (GLOBE) http://www.globe-network.org/en/about-globe

GLOBAL ALLIANCE FOR CHRONIC DISEASE http://www.gacd.org/ Programme for Global Health and Vaccination Research – GLOBVAC

http://www.forskningsradet.no/prognett-globvac/Home_page/1224697869238

THANK YOU VERY MUCH!

ERIKA SELA

INNOVATEC

Erika.sela@innovatec.es

www.innovatec.es